Doctoral Students in Molecular Medicine and Bioinformatics


As part of the Nordic EMBL Partnership for Molecular Medicine, FIMM is seeking outstanding candidates for positions of

Doctoral Students in Molecular Medicine and Bioinformatics 

starting in August 2019
FIMM ( is an international research institute focusing on human genomics and personalized medicine at the Helsinki Institute of Life Science of the University of Helsinki. FIMM integrates molecular medicine research, technology centre and biobanking infrastructures under one roof promoting translational research in grand challenge projects, specifically, the impact of genome information from the Finnish population in personalized health and medicine, individualized cancer medicine, and digital molecular medicine. The areas of interest of the 20 research groups cover cancer, cardiovascular disease, immune disorders, and neurological and psychiatric diseases.  
FIMM works together with the University of Helsinki Doctoral School in Health Sciences (DSHealth) and doctoral programs ( to provide excellent training and courses aimed at a doctoral degree at the University of Helsinki.
As part of an annual international joint call of the Nordic EMBL Partnership for Molecular Medicine, we currently have 2-3 openings for doctoral students who show outstanding potential to become independent researchers and who will significantly benefit from the FIMM-EMBL International PhD rotational training. Specifically, these positions are in the fields of molecular medicine, bioinformatics and computational biomedicine.
Detailed information about the research areas in this call can be found at the following webpage:

Qualifications and experience:

Candidates are expected to have a second cycle academic degree (MSc, MD or equivalent) in biology, biochemistry, bioinformatics, biotechnology, cell biology, computer science, data science, genetics, mathematics, medicine, statistics or other related fields, obtained before the start of the position (August 2019). The successful candidate will have good problem solving, troubleshooting, and analytical skills. In addition, the candidate should be fluent in English, have good interpersonal and written and oral communication skills, and be able to work independently as well as in an international team. 

Application and selection process:

Candidates are invited to apply online at no later than February 7, 2019 at 23:59 Eastern European Time.  
To apply, applicants should submit to the online system the following materials prepared in English:
  • Application form
  • CV or resume (maximum 2 pages)
  • Cover and motivation letter (maximum 2 pages) describing, in separate sections, 1) previous and current research experience and studies, 2) motivation for pursuing doctoral studies, and 3) research interests and how these match the research groups at FIMM 
The letter and CV must be submitted as a single PDF file named with the candidate’s surname. Please note that candidates are expected to carefully follow the application instructions above. Applications submitted after the deadline, failing to meet the requirements above, or sent directly to group leaders will not be considered.
Application review will begin after the close of the call. Top candidates will be invited for an interview with a selection committee in mid-April 2019. The final candidates selected for the positions will be offered an initial contract for 18 months, during the first half of which they will engage in training through research group rotations. Upon a successful review and selection of a research group after the rotational period, the initial contract will be extended up to a four-year period. 
For further information about:
FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centers for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community. In the beginning of 2017 FIMM joined the University of Helsinki’s new life science research centre, Helsinki Institute of Life Science HiLIFE, as an operational unit.
Helsinki 18 December 2018
Institute for Molecular Medicine Finland FIMM
Last updated: 07.01.2019 - 00:15